Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.67 |
| ▸ | NPC1 | O15118 | 4/20 | 0.62 |
| ▸ | RAB9A | P51151 | 4/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.62 |
| ▸ | TGFBR1 | P36897 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | WDR5 | P61964 | 1/20 | 0.46 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11477397 | 0.90 | ATM (0.72) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 | |
| SCHEMBL27309763 | 0.88 | ATM (0.61) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 | |
| SCHEMBL15452608 | 0.85 | TGFBR1 (0.72) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 | |
| SCHEMBL7381132 | 0.84 | TGFBR1 (0.67) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 | |
| SCHEMBL17767606 | 0.81 | TGFBR1 (0.61) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 | |
| SCHEMBL9436323 | 0.80 | TGFBR1 (0.63) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 | |
| SCHEMBL9701303 | 0.80 | TGFBR1 (0.62) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 | |
| SCHEMBL17767506 | 0.78 | TGFBR1 (0.64) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 | |
| SCHEMBL9700033 | 0.77 | TGFBR1 (0.83) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 | |
| SCHEMBL11475818 | 0.76 | WDR5 (0.56) | ATMNPC1RAB9ASMN1; SMN2TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0306300-B1 | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORP (US) | 1995-05-03 | — | — | EP | claimed |
| CN-1032011-A | Pyrrolo-imidazoles and imidazopyridine and application thereof | SMITHKLINE BECKMAN CORP (US) | 1989-03-29 | — | — | CN | claimed |
| EP-0306300-A2 | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1989-03-08 | — | — | EP | claimed |
| EP-0306300-B1 | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORP (US) | 1995-05-03 | — | — | EP | disclosed |
| US-5145858-A | Antiinflammatory | SMITHKLINE BEECHAM CORP. (US) | 1992-09-08 | — | — | US | disclosed |
| US-5002941-A | Antiarthritic agents, arachidonic acid metabolism | SMITHKLINE BEECHAM CORPORATION (US) | 1991-03-26 | — | — | US | disclosed |
| WO-1990003789-A1 | PYRROLO[1,2-a]IMIDAZOLE AND IMIDAZO[1,2-a]PYRIDINE DERIVATIVES AND THEIR USE AS 5-LYPOXYGENASE PATHWAY INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1990-04-19 | — | — | WO | disclosed |
| EP-0364204-A1 | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1990-04-18 | — | — | EP | disclosed |
| CN-1032011-A | Pyrrolo-imidazoles and imidazopyridine and application thereof | SMITHKLINE BECKMAN CORP (US) | 1989-03-29 | — | — | CN | disclosed |
| EP-0306300-A2 | Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors | SMITHKLINE BEECHAM CORPORATION (US) | 1989-03-08 | — | — | EP | disclosed |